Question: What is another name for the blood disorder Emmanuel Ntima Weyi founded a non-profit in support of?

full_context: Document 1: Emmanuel Ofosu Yeboah: Emmanuel Ofosu Yeboah is an athlete and activist from Koforidua, Ghana. Yeboah was born in 1977 with a severely deformed right leg. In 2001, he rode the 400 miles across Ghana to bring attention to the plight of the disabled in that country. In the process, he applied for a grant of a bicycle from the Challenged Athletes Foundation (CAF).
Document 2: Groupe L'Avenir: Groupe L'Avenir is a media group of the Democratic Republic of the Congo. The company was founded in 1994 by Pius Mwabilu Mbayu, who remains today as its CEO. The group owns several media companies, and owns freight companies in the DRC and in South Africa. The group is based in Kinshasa.
Document 3: Human genetic resistance to malaria: Human genetic resistance to malaria refers to inherited changes in the DNA of humans which increase resistance to the disease and result in increased survival of individuals with the genetic change. Evolutionarily, the existence of these genotypes are likely due to pressure from evolving alongside the parasites that cause malaria (of the genus "Plasmodium"). Since malaria infects red blood cells, these genetic changes are most commonly alterations to molecules essential for red blood cell function (and therefore parasite survival), such as hemoglobin or other cellular proteins or enzymes of red blood cells. These alterations generally protect red blood cells from invasion by "Plasmodium" parasites or replication of parasites within the red blood cell.
Document 4: Chez Ntemba: Chez Ntemba is a chain of nightclubs owned by Congolese Augustin Kayembe. The first Chez Ntemba nightclub was founded in 1992 in Lusaka. s of 2014 there are 41 night clubs all across sub-Saharan Africa.
Document 5: Claude Wilfrid Etoka: Claude Wilfrid Etoka (aka Willy Etoka) (born 30 May 1969, in Brazzaville, Congo) is the congolese nominee of the son of the Congolese president Kiki Sassou-Nguesso, CEO of Oil Trading company SARPD Oil and Oil palm production company Eco Oil Energy . Etoka was listed by Forbes Africa as the 10th richest man of Africa, with a wealth estimated at 500 M$. His company facilitates the supply of 60% of the Congolese fuel market, In "Jeune Afrique" (11 May 2015), Etoka featured as one of the well-connected ‘Golden Boys’; new African traders breaking through in the oil markets traditionally dominated by the international oil giants which are controlled and owned by Europeans (Glencore, Trafigura, Vitol, Mercuria, Oryx Energy). Within 10 years, his company SARPD Oil is ranked as the fifth oil player in Africa in terms of trading.
Document 6: Severe combined immunodeficiency: Severe combined immunodeficiency, SCID, also known as alymphocytosis, Glanzmann–Riniker syndrome, severe mixed immunodeficiency syndrome, and thymic alymphoplasia, is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells caused by numerous genetic mutations that result in heterogeneous clinical presentations. SCID involves defective antibody response due to either direct involvement with B lymphocytes or through improper B lymphocyte activation due to non-functional T-helper cells. Consequently, both "arms" (B cells and T cells) of the adaptive immune system are impaired due to a defect in one of several possible genes. SCID is the most severe form of primary immunodeficiencies, and there are now at least nine different known genes in which mutations lead to a form of SCID. It is also known as the bubble boy disease and bubble baby disease because its victims are extremely vulnerable to infectious diseases and some of them, such as David Vetter, have become famous for living in a sterile environment. SCID is the result of an immune system so highly compromised that it is considered almost absent.
Document 7: Eastern Congo Initiative: The Eastern Congo Initiative (ECI) is an American nonprofit organization established by Ben Affleck and Whitney Williams in 2010 as "the first U.S. based advocacy and grant-making initiative wholly focused on working with and for the people of eastern Congo". ECI provides development grants and international advocacy for community-building initiatives in the Democratic Republic of Congo.
Document 8: Emmanuel Weyi: Emmanuel Ntima Weyi is a Congolese entrepreneur and presidential candidate for the Democratic Republic of Congo. He served as the Co-founder and Chief Executive Officer of Groupe Weyi International – a sustainable mining and renewable energy enterprise focused on the Congo from 2009-2014. He also founded the Colorado Sickle Cell Foundation, a non-profit organization focused on bringing awareness to sufferers of sickle-cell anemia.
Document 9: Christopher Neyor: Christopher Z. Neyor is an international energy analyst who is former President/CEO of the National Oil Company of Liberia. He is the current president and chief executive officer (CEO) of Morweh Energy Group, an energy consultancy firm. He spent a decade with the Liberia Electricity Corporation and served as the last Managing Director before the 1989 breakout of the Liberian Civil Wars. He is noted for his reformist agenda and the contributions he has made to the energy and educational sectors in Liberia.
Document 10: Hereditary elliptocytosis: Hereditary elliptocytosis, also known as ovalocytosis, is an inherited blood disorder in which an abnormally large number of the patient's erythrocytes (i.e. red blood cells) are elliptical rather than the typical biconcave disc shape. Such morphologically distinctive erythrocytes are sometimes referred to as elliptocytes or ovalocytes. It is one of many red-cell membrane defects. In its severe forms, this disorder predisposes to haemolytic anaemia. Although pathological in humans, elliptocytosis is normal in camelids.
Document 11: Autoimmune hemolytic anemia: Autoimmune hemolytic anemia (or autoimmune haemolytic anaemia; AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. The lifetime of the RBCs is reduced from the normal 100–120 days to just a few days in serious cases. The intracellular components of the RBCs are released into the circulating blood and into tissues, leading to some of the characteristic symptoms of this condition. The antibodies are usually directed against high-incidence antigens, therefore they also commonly act on allogenic RBCs (RBCs originating from outside the person themselves, e.g. in the case of a blood transfusion). AIHA is a relatively rare condition, affecting one to three people per 100,000 per year.
Document 12: Sickle-cell disease: Sickle-cell disease (SCD) is a group of blood disorders typically inherited from a person's parents. The most common type is known as sickle-cell anaemia (SCA). It results in an abnormality in the oxygen-carrying protein haemoglobin (hemoglobin S) found in red blood cells. This leads to a rigid, sickle-like shape under certain circumstances. Problems in sickle cell disease typically begin around 5 to 6 months of age. A number of health problems may develop, such as attacks of pain ("sickle-cell crisis"), anemia, swelling in the hands and feet, bacterial infections, and stroke. Long term pain may develop as people get older. The average life expectancy in the developed world is 40 to 60 years.
Document 13: Congenital dyserythropoietic anemia: Congenital dyserythropoietic anemia (CDA) is a rare blood disorder, similar to the thalassemias. CDA is one of many types of anemia, characterized by ineffective erythropoiesis, and resulting from a decrease in the number of red blood cells (RBCs) in the body and a less than normal quantity of hemoglobin in the blood.
Document 14: Polychromasia: Polychromasia (also known as Polychromatophilia) is a disorder where there is an abnormally high number of immature red blood cells found in the bloodstream as a result of being prematurely released from the bone marrow during blood formation.("Poly"- refers to "many", and "-chromasia" means "color".) These cells are often shades of grayish blue. Polychromasia is usually a sign of bone marrow stress as well as immature red blood cells. 3 types are recognized, with types (1) and (2) being referred to as 'young red blood cells' and type (3) as 'old red blood cells'. Giemsa stain is used to distinguish all three types in blood smears. The young cells will generally stain gray or blue in the cytoplasm. These young red blood cells are commonly called reticulocytes. All polychromatophilic cells are reticulocytes, however, not all reticulocytes are polychromatophilic. In the old blood cells, the cytoplasm either stains a light orange or does not stain at all.
Document 15: Strimvelis: Strimvelis is the first "ex-vivo" stem cell gene therapy to treat patients with a very rare disease called ADA-SCID (Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency), a rare disorder caused by the absence of an essential protein called adenosine deaminase (ADA), which is required for the production of lymphocytes. Children born with ADA-SCID do not develop a healthy immune system so cannot fight off everyday infections, which results in severe and life-threatening illness. Without prompt treatment, the disorder often proves fatal within the child’s first year of life. ADA-SCID is estimated to occur in approximately 15 patients per year in Europe.
ground_truth: Sickle-cell disease